FDA Inspection 1043275 — AGC Biologics A/S
The FDA completed an inspection of AGC Biologics A/S on Nov 7, 2017 in Soborg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Soborg (Denmark)